Thursday Sep 25 | Drugs.com
Array BioPharma Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 Diabetes
Sep 25, 2008 - Array BioPharma Inc. today announced the presentation of preclinical data on a novel small molecule glucokinase activator , ARRY-403, a drug for the treatment of Type 2 diabetes.
Array BioPharma to Present at the Thomas Weisel Partners 2008 Healthcare Conference
Aug 27, 2008 - Array BioPharma Inc. today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Thomas Weisel Partners 2008 Healthcare Conference on September 3 in Boston.
Array BioPharma sees '09 revenue below Street view
Array BioPharma Inc on Tuesday forecast first-quarter and fiscal 2009 revenue below analysts' estimates, a day after it posted wider quarterly loss, sending its shares down as much as 11 percent.
Bear Creek biology teacher gets chance at industry work
Tamra Miaja , a biology teacher at Lakewood's Bear Creek High School , is the first teacher to take part in a pilot "externship" program organized by the Colorado BioScience Association , a 400-member trade ...
Identification of 4-Aminopyrazolylpyrimidines as Potent Inhibitors of Trk Kinases
Michelle L. Lamb , † David A. Scott , † Haixia Wang , † Michael H. Block , † Paul D. Lyne , † John W. Lee , † Audrey M. Davies , † Hai-Jun Zhang , † Yanyi ...
Identification of 4-Aminopyrazolylpyrimidines as Potent Inhibitors of Trk Kinases
Michelle L. Lamb , † David A. Scott , † Haixia Wang , † Michael H. Block , † Paul D. Lyne , † John W. Lee , † Audrey M. Davies , † Hai-Jun Zhang , † Yanyi ...
Public relations, press release distribution, investor relations, SEC filing
Array BioPharma Inc. today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Collins Stewart 4 - CHICAGO-- --Creative agency 50,000feet announced the launch of a new brand identity ...
Public relations, press release distribution, investor relations, SEC filing
Array BioPharma Inc. today announced that its Chief Medical Officer, John Yates, M.D., presented additional positive results from a Phase 1 - RESTON, Va.-- --NCI, Inc.
Array BioPharma and AstraZeneca Announce New Phase 2 Development...
BOULDER, Colo. - Array BioPharma Inc. and AstraZeneca today announced plans for two additional randomized Phase 2 trials for AZD6244 . via Earth Times
Public relations, press release distribution, investor relations, SEC filing
Parallel Petroleum Corporation today announced its financial results for the first quarter ended March 31, 2008, compared to the results for - 05/05/2008 - 04:30 PM BOULDER, Colo.-- --Array BioPharma Inc. via Business Wire
Public relations, press release distribution, investor relations, SEC filing
Array BioPharma Inc. , today announced that it has received an $80 million funding commitment from Deerfield Management, a leading healthcare - 05/05/2008 - 04:28 PM BRANFORD, Conn.-- --Neurogen Corporation , a ... via Business Wire
Posted Tue May 06, 02:38 pm ET Posted By: Grant Zeng, CFA Array BioPharma, Inc. focuses on developing orally active drugs by utilizing the latest advances in chemistry, biology and informatics. via Zacks Analyst Blog
“We believe this financing structure achieves our objective of maintaining adequate capital reserves to fund our robust proof-of-concept trials while minimizing shareholder dilution”
Array BioPharma Inc. , today announced that it has received an $80 million funding commitment from Deerfield Management, a leading healthcare investment organization and one of Array's largest shareholders. via BioSpace
The Boulder County Business Report
A wide variety of local business, political and community leaders will gather Thursday, May 15, for Boulder's first economic summit. via The Boulder County Business Report
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008
Apr 30, 2008 - Array BioPharma Inc. will report financial results for the third quarter of fiscal 2008 on Monday, May 5, 2008, and will hold a conference call on Tuesday, May 6, 2008, at 9:00 a.m. eastern time ... via Med Ad News
Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
“With the capability to also accommodate services spend through outside vendors, SciQuest makes maverick spending a non-issue.”
SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that Array BioPharma Inc., a leading ... via Med Ad News
Senior Clinical Study Manager - North Carolina
Description Array BioPharma is located in Boulder, CO and is opening a 2nd location in Morrisville, NC. via BioSpace
Array BioPharma is located in Boulder, CO and is opening a 2nd location in Morrisville, NC. via BioSpace
The Sun heaves out a load of space weather that can impact the Earth. Shown here is the Sun's outer atmosphere - known as the Corona - taken by instruments onboard the National Oceanic and Atmospheric ... via SPACE.com
A Little Bit of Cash for ArQule
Like other chemistry or drug discovery specialists, such as Pharmacopeia and Array BioPharma , ArQule has partnerships with a number of big pharmaceutical companies that it helps identify suitable drug ... via Fool.com
Read more articles in the Array BioPharma News Archives.
For up to the minute news, check out the Array BioPharma News Wire.
Want to add Array BioPharma News headlines to your web site? Get the widget here.
Comment?
Array BioPharma Poll
Top Stories
Most Popular
Recent Forum Discussions
News Trends
